Trial NCT04407442

View at ClinicalTrials.gov 
Org. Study IDs: 20251
Secondary IDs: NCI-2020-02985

Last trial update was posted on 2023-07-21

MeSH Interventions

Azacitidine BB 1101 Daratumumab Dexamethasone Dexamethasone acetate Ichthammol

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Stopping Reasons

Slow enrollment and change in sponsor direction

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID